UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549



FORM 8-K



CURRENT REPORT
Pursuant to Section 13 or 15(d)
of The Securities Exchange Act Of 1934
 
Date of Report (Date of earliest event reported): December 22, 2022



ATI PHYSICAL THERAPY, INC.
(Exact name of registrant as specified in its charter)
 


Delaware
001-39439
85-1408039
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)

790 Remington Boulevard





Bolingbrook, Illinois

60440
(Address of principal executive offices)

(Zip Code)
 
(630) 296-2223
(Registrant’s telephone number, including area code)
 

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class

Trading
Symbol

Name of Each Exchange
on Which Registered




 
Class A Common Stock, $0.0001 par value

ATIP

New York Stock Exchange
Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
ATIP WS

New York Stock Exchange
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
 
Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 


Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
 
 Appointment of New Chief Operating Officer

ATI Physical Therapy, Inc. (the “Company”) announced the appointment of Scott Gregerson as the Company’s Chief Growth Officer to be effective as of January 3, 2023 (the “Effective Date”).

Mr. Gregerson has held executive leadership positions at Envison Healthcare, Epic Care, Stanford Healthcare and ValleyCare Health. In these chief-executive, presidential and vice-presidential roles he developed and led strategic business development and growth, often connecting large-scale provider groups with hospital and health systems. His prior experience also includes healthcare leadership positions at Fresenius Medical Care (Chicago), Doctors Community Hospital (Lanham, MD) and Sonoma Valley Hospital (Sonoma, Calif). Mr. Gregerson holds a bachelor’s degree from the University of California, Santa Barbara and a juris doctor degree from Washington and Lee University School of Law.

In connection with his appointment, the Company and Mr. Gregerson have entered into a written employment agreement (the “Employment Agreement”) for an initial term of three-years that automatically renews for one-year terms thereafter, unless notice of non-renewal is provided 30 days before the end of the term then in effect, and a minimum base salary of $490,000 per year. In addition, the Employment Agreement provides for an annual target bonus equal to 75 % of his base salary (“Target Bonus”), also be granted long-term incentive equity awards for 2023 pursuant to the Company’s 2021 Equity Incentive Plan, with a grant-date fair market value of $500,000 in 2023 as determined by the Compensation Committee. Each annual grant is to be comprised of 100% of restricted stock units vesting in three equal annual tranches. Mr. Gregerson is eligible to participate in the Company’s employee benefit plans as in effect from time to time on the same basis as generally made available to other senior executives of the Company.

In addition, the Employment Agreement also provides for certain payments and benefits in the event of a termination of his employment under specific circumstances. If, during the term of the Employment Agreement, his employment is terminated by the Company other than for “Discharge For Cause,” death or disability (each as defined in his agreement), he would be entitled to:  (a) upon termination at any time other than during the 18-month period following a Change in Control (as defined in his agreement), (i) an amount equal to 1.25 times the sum of (x) Mr. Gregerson’s base salary and (y) Target Bonus, in substantially equal installments over 15 months from termination, (ii) an annual bonus for the then-current fiscal year based on actual performance for such year, pro-rated from the first date of such fiscal year through Mr. Gregerson’s last date of continued active employment, payable at the same time as annual bonuses are paid other senior executives of the Company and (iii) if elected, the employer and employee portion of any COBRA health and welfare premiums for a period equal to twelve (12) months from the date of termination, or, if earlier, (x) the first date that Mr. Gregerson is no longer eligible for COBRA, or (y) the first date that Mr. Gregerson becomes eligible for health benefits from another employer; or (b) upon termination during the 18-month period following a Change in Control (i) an amount equal to 1.5 times the sum of (x) Mr. Gregerson’s base salary and (y) Target Bonus, in a lump sum on the first payroll date, (ii) an annual bonus for the then-current fiscal year based on actual performance for such year, pro-rated from the first date of such fiscal year through Mr. Gregerson’s last date of continued active employment, payable at the same time as annual bonuses are paid other senior executives of the Company, (iii) if elected, the employer and employee portion of any COBRA health and welfare premiums for a period equal to twelve (12) months from the date of such termination, or, if earlier, (x) the first date that Mr. Gregerson is no longer eligible for COBRA or (y) the first date that Mr. Gregerson becomes eligible for health benefits from another employer.

Mr. Gregerson’s receipt of the termination payments and benefits is contingent upon execution of a general release of any and all claims arising out of or related to his employment with the Company and the termination of his employment, and compliance with the restrictive covenants described in the following paragraph.

Pursuant to his Employment Agreement, Mr. Gregerson has also agreed to customary restrictions with respect to the disclosure and use of the Company’s confidential information and has agreed that work product or inventions developed or conceived by his while employed with the Company relating to its business is the Company’s property. In addition, during the term of his employment and for the 15-month period following his termination of employment if Mr. Gregerson is eligible to receive severance benefits and an 12-month period following his termination in any other circumstance, Mr. Gregerson has agreed not to (1) perform services on behalf of a competing business which was the same or similar to the types services he was authorized, conducted, offered or provided to the Company, (2) solicit or induce any of the Company’s employees or independent contractors to terminate their employment with the Company or (3) solicit any actual or prospective customers with whom he had contact on behalf of a competing business. In addition, his Employment Agreement mandates that his confidentiality obligations continue after the termination of employment.


Mr. Gregerson has no family relationship with any of the executive officers or directors of the Company. There are no arrangements or understandings between Mr. Gregerson and any other person pursuant to which he was appointed as an officer of the Company.

The foregoing summary of the Employment Agreement does not purport to be complete and is qualified in its entirety by reference to the      complete text of the Employment Agreement, a copy of which is attached as Exhibit 10.1.

Item 9.01
Financial Statements and Exhibits

(d) Exhibits

EXHIBIT
NUMBER

DESCRIPTION

Employment Agreement effective December 16, 2022 by and between ATI Physical Therapy, Inc. and Scott Gregerson



104

Cover Page Interactive Data File (embedded within the Inline XBRL document)
 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Dated: December 22, 2022
ATI Physical Therapy, Inc.



By:
/s/ Joseph Jordan

Name:
Joseph Jordan

Title:
Chief Financial Officer



ATI Physical Therapy (NYSE:ATIP)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more ATI Physical Therapy Charts.
ATI Physical Therapy (NYSE:ATIP)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more ATI Physical Therapy Charts.